OGN Organon & Co.
13.70USD-0.15%Mkt Cap: 3.60B $P/E: 17.56Today
Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, …
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap3.60B USD
Enterprise Value11.02B USD
Revenue (TTM)6.13B USD
Gross Profit3.31B USD
Net Income (TTM)187.00M USD
Revenue/Share23.49 USD
Last Price13.70 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)17.56
P/E (Forward)3.80
PEG—
EV/EBITDA7.05
EV/Revenue1.80
P/S0.59
P/B3.58
EPS (TTM)0.78
EPS (Forward)3.62
52W Range
5.69099% of range13.78
52W High13.78 USD
52W Low5.690 USD
Profitability
Gross Margin53.30%
Oper. Margin20.73%
EBITDA Margin25.53%
Profit Margin3.01%
ROE24.87%
ROA1.45%
Growth
Revenue Growth-2.30%
Earnings Growth-28.30%
Cash Flow & Leverage
Operating CF700.00M USD
CapEx (TTM)316.00M USD
FCF Margin8.01%
FCF Yield13.64%
Net Debt7.42B USD
Net Debt/EBITDA4.74
Balance Sheet
Debt/Equity11.49
Current Ratio1.95
Quick Ratio1.00
Book Value/Sh3.83 USD
Cash/Share4.31 USD
Dividends
Fwd Div Rate0.08 USD
Trail. Div Rate0.08 USD
Div. Yield0.58%
5Y Avg Yield2.50%
Payout Ratio10.26%
Ex-Div DateAug 14, 2026
Pay DateSep 10, 2026
Analyst Consensus
Rating—
Target (Mean)11.25 USD
Upside (mean)-17.9%
Target Range8.000 USD – 14.00 USD
8.000-17.9% to mean14.00
# Analysts4
Ownership
Shares Out.262.61M
Float242.99M
Insiders0.46%
Institutions84.76%
Short Interest
Short Ratio5.5d
Short % Float7.59%
Short % Out.6.68%
Shares Short17.53M
Short (prev mo.)15.14M
Technical
SMA 5013.68 (+0.2%)
SMA 20010.89 (+25.8%)
Beta1.52
S&P 52W Chg14.58%
Avg Vol (30d)2.73M
Avg Vol (10d)1.88M
Technical Indicators
RSI (14)55.4
MACD0.0129
MACD Signal0.0146
MACD Hist.-0.0017
BB Upper13.78 USD
BB Middle13.70 USD
BB Lower13.62 USD
BB Width1.15%
ATR (14)0.0389 USD
Vol Ratio (20d)0.80x